NCT06634732

Brief Summary

This is a prospective observational study to observe the diagnostic efficacy of a quantitative ultrasound assessment plan for pathological accumulation in the abdominal cavity space of critically ill patients, and to explore its correlation with patient clinical outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 10, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 10, 2024

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

September 19, 2024

Last Update Submit

October 8, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Quantitative CT Scoring for Pathological Accumulations in the Abdominal Cavity Space

    score range from 0-20, higher scores indicate a worse outcome

    up to 3 days after admission to ICU

  • Quantitative Ultrasound Scoring for Pathological Accumulations in the Abdominal Cavity Space

    score range from 0-20, higher scores indicate a worse outcome

    up to 3 days after admission to ICU

Secondary Outcomes (18)

  • Time to initiate enteral nutrition

    up to 3 days after admission to ICU

  • Intra-abdominal pressure

    up to 3 days after admission to ICU

  • C-reactive protein

    up to 3 days after admission to ICU

  • procalcitonin

    up to 3 days after admission to ICU

  • white blood cell count

    up to 3 days after admission to ICU

  • +13 more secondary outcomes

Study Arms (1)

observational group

Subjectives will undergo abdominal ultrasound examination immediately after receiving an abdominal CT scan.after admission to the ICU.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients in the Department of Critical Care Medicine at Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University

You may qualify if:

  • Age \> 18 years old;
  • Expected ICU stay ≥ 72 hours;
  • Meeting one of the diagnostic criteria for intra-abdominal infection: 1) Single organ infection (such as cholecystitis, appendicitis, diverticulitis, cholangitis, pancreatitis, salpingitis, etc.), which may be accompanied by or without peritonitis, even without perforation; 2) Peritonitis, classified as primary, secondary, or recurrent; 3) Intra-abdominal abscess.

You may not qualify if:

  • Patients with wounds, redness, swelling, bleeding, or other conditions at the abdominal measurement points that prevent ultrasound assessment;
  • Patients with intra-abdominal gas accumulation that affects abdominal ultrasound imaging, making ultrasound quantitative scoring impossible;
  • Patients who have not undergone abdominal CT examination within 72 hours of ICU admission;
  • Patients who do not consent to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

SepsisMultiple Organ FailureShock

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

weiqing Zhang, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2024

First Posted

October 10, 2024

Study Start

November 1, 2024

Primary Completion

August 1, 2025

Study Completion

December 31, 2025

Last Updated

October 10, 2024

Record last verified: 2024-09

Locations